Evidence map›Paper›PMID 34410570›Full record

ArticleJournal of molecular neuroscience : MN2022

Association of antioxidant deficiency and the level of products of protein and lipid peroxidation in patients with the first episode of schizophrenia.

Anna Sergeevna Piatoikina, Anastasia Alexandrovna Lyakhova, Ilya Vladimirovich Semennov, Tatyana Vladimirovna Zhilyaeva, Olga Vladimirovna Kostina, Ekaterina Sergeevna Zhukova, Tatyana Grigorievna Shcherbatyuk, Evgeny Dmitrievich Kasyanov, Anna Sergeevna Blagonravova, Galina Elevna Mazo

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Oxidative Stress and Emergence of Psychosis.Antioxidants (Basel, Switzerland) · 2022
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Anna Sergeevna PiatoikinaState Budgetary Institution of Public Health of Nizhny Novgorod Region Nizhny Novgorod Clinical Psychiatric Hospital No. 1, Nizhny Novgorod, Russia. annapiatoikina@yandex.ru.ORCID http://orcid.org/0000-0002-8932-7418
Anastasia Alexandrovna LyakhovaFederal State Budgetary Research Institution of Higher Education Privolzhsky Research Medical University of the Ministry of Public Health of the Russian Federation, Nizhny Novgorod, Russia.
Ilya Vladimirovich SemennovFederal State Budgetary Research Institution of Higher Education Privolzhsky Research Medical University of the Ministry of Public Health of the Russian Federation, Nizhny Novgorod, Russia.
Tatyana Vladimirovna ZhilyaevaFederal State Budgetary Research Institution of Higher Education Privolzhsky Research Medical University of the Ministry of Public Health of the Russian Federation, Nizhny Novgorod, Russia.
Olga Vladimirovna KostinaFederal State Budgetary Research Institution of Higher Education Privolzhsky Research Medical University of the Ministry of Public Health of the Russian Federation, Nizhny Novgorod, Russia.
Ekaterina Sergeevna ZhukovaFederal Budgetary Institution of Science Nizhny Novgorod Research Institute for Hygiene and Occupational Pathology of Rospotrebnadzor, Nizhny Novgorod, Russia.
Tatyana Grigorievna ShcherbatyukFederal Budgetary Institution of Science Nizhny Novgorod Research Institute for Hygiene and Occupational Pathology of Rospotrebnadzor, Nizhny Novgorod, Russia.
Evgeny Dmitrievich KasyanovFederal State Budgetary Institution V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, Saint-Petersburg, Russia.
Anna Sergeevna BlagonravovaFederal State Budgetary Research Institution of Higher Education Privolzhsky Research Medical University of the Ministry of Public Health of the Russian Federation, Nizhny Novgorod, Russia.
Galina Elevna MazoFederal State Budgetary Institution V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, Saint-Petersburg, Russia.
Privolzhsky Research Medical University · RUNizhny Novgorod Research Institute of Traumatology and Orthopedics · RUSt.Petersburg V.M.Bekhterev Psychoneurological Research Institute · RUMoscow Region State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is considered a multifactorial disease, where one of the pathogenetic links is oxidative stress; however, the results of studies are often contradictory, largely due to significant heterogeneity among study methods. The present study was undertaken to compare the levels of oxidative stress markers in the peripheral blood of patients with a first episode of schizophrenia (FES) and in healthy volunteers (HV). The study included 50 patients with FES and 37 HV. Blood samples were collected for spectrophotometric assessment of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), aldehyde-2,4-dinitrophenylhydrazone (ADNPH), and ketone-2,4-dinitrophenylhydrazone (KDNPH) in blood plasma. Results showed that in patients with FES compared with HV, a significant decrease in CAT activity and an increase in oxidative modification of proteins (OMP) were found. In both groups, a significant increase in the level of MDA with age was revealed. In patients, the GSH plasma level was inversely proportional to the ADNPH level, and SOD activity was directly proportional to the KDNPH level. In volunteers there was no such correlation; however, there was a direct correlation between CAT activity and the levels of OMP and MDA. In both groups, a moderate direct correlation between peroxidation products was observed. The results confirm that a redox imbalance (a deficiency of antioxidants, in particular CAT, and excess OMP) may be a pathogenetic link in schizophrenia, which is manifested already at an early stage of the disease.

Indexed as

AntioxidantsSchizophreniaCatalaseGlutathione PeroxidaseHumansLipid PeroxidationMalondialdehydeOxidative StressSuperoxide DismutaseAntioxidantsCatalaseGlutathione PeroxidaseMalondialdehydeSuperoxide DismutaseCatalaseGlutathioneMalondialdehydeOxidative modification of proteinsOxidative stressSchizophreniaSuperoxide dismutase

Identifiers

PMID34410570
OpenAlexW3194257422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.